Skip to content

Investigating the Effect of Adherence to Therapeutic Regimen program on the Quality of Life in Patients with Atrial Fibrillation

Investigating the Effect of Adherence to Therapeutic Regimen program on the Quality of Life in Patients with Atrial Fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190203042608N1
Enrollment
50
Registered
2019-12-29
Start date
2018-01-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation. Persistent atrial fibrillation

Interventions

Intervention 1: A compiled therapeutic regimen program which is a synthesis of personal training and practicing in two 45-minute successive sessions. On the second and third days of hospitalization, d

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 7- The Main Inclusion criteria in the Study before Randomization Those patients with atrial fibrillation arrhythmia diagnosed and treated by cardiologist specialists. Those patients with atrial fibrillation arrhythmia hospitalized for the first time. Those patients that are in the age range between 35 and 70 years old

Exclusion criteria

Exclusion criteria: Patients’ disinclination to participate in the intervention Patients’ with physical and psychological problems leading to their disabilities 3. Patients below 35 years old and above 70 years old

Design outcomes

Primary

MeasureTime frame
The quality-of-life in patients with atrial fibrillation in the AFEQT questionnaire. Timepoint: Investigating the quality of life at the study outset, one month and three months after the intervention. Method of measurement: The atrial fibrillation effect on the quality-of-life questionnaire.

Secondary

MeasureTime frame
The atrial fibrillation symptoms including heartbeat, chest pain, shortness of breath, and vertigo. Timepoint: All items accomplished before the intervention, and one month and three months after the intervention. Method of measurement: All items are from the atrial fibrillation effect on the quality-of-life questionnaire for the patients with atrial fibrillation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Yazdizadeh

Esfahan University of Medical Sciences

yazdizadeh.f71@gmail.com+98 83 3835 8258

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026